The Xvent homeobox multigene family is essential for the patterning of the ventral mesoderm in Xenopus embryos. We have identified two novel members of this family, Xvent-1B and Xvent-2B, and have characterized their genomic structures. These two genes show a clustered organization and have probably arisen by gene duplication with subsequent inversion. Cis-regulatory elements within the promoters of both genes have been identified which contribute to their spatial activation. Xvent-2B is activated by BMP-2/4 in the absence of de novo protein synthesis, suggesting that this gene is a direct target of BMP-signalling. In contrast, Xvent-1B does not directly respond to BMP-2/4, but is activated by Xvent-2B. This activation is documented by Xvent-1B promoter/reporter studies, Xvent-2B overexpression and loss-of-function analysis using a dominant-negative Xvent-2 mutant. However, cycloheximide experiments reveal that Xvent-2B by itself is not sufficient to activate transcription of the Xvent-1B gene, but that there is a requirement for additional factor(s) being synthesized after midblastula transition.
Introduction
Bone morphogenetic protein 4 (BMP-4) is regarded as a key molecule in patterning the ventral mesoderm during vertebrate embryogenesis (for review see Hogan, 1996) . Ectopic expression within the dorsal mesoderm leads to completely ventralized embryos (Dale et al., 1992; Jones et al., 1992) and disruption of BMP signalling in ventral mesoderm results in dorsalization and formation of a second body axis (Graff et al., 1994; Suzuki et al., 1994) . While the function of the dorsal lip, the Spemann organizer, has recently been reconciled (Graff, 1997) in that its primary function is to synthesize BMP-4 antagonists, like chordin, noggin and follistatin, the molecular mechanisms underlying the ventalization and dorsalization processes are widely unknown. Promoter studies of the dorsal lip specific early response genes goosecoid and XFD-1′ (XFKH-1) revealed that both genes can be activated within the ventral/vegetal region of the embryo when silencing elements were removed from their promoters (Watabe et al., 1995; Kaufmann et al., 1996) . In case of the XFD-1′ gene it was shown that BMP-4 inhibited ventral expression of the wild type gene and, as a silencer, a BMP triggered inhibitory promoter element (BIE) was identified. Thus it seems that the ventralization process implies a suppression of dorsal gene activities and that the spatial expression of dorsal lip specific genes is not only the result of local activation but may be considered as a consequence from the lack of inhibition by BMPs.
The best candidate genes in mediating the effects of BMP are the recently discovered Xvent homeobox genes (for review see Lemaire, 1996) which show a characteristic isoleucine or valine to threonine exchange within the third helix of the homeodomain similar to that found in human HOX11 (Kennedy et al., 1991) and Drosophila homeoproteins, BarH1 (Kojima et al., 1991) and Om(1D) (Tanda and Corces, 1991) . Members of the Xvent family can be divided into two subfamilies, one containing Xvent-1 and PV.1 (Gawantka et al., 1995; Tidman Ault et al., 1996) , the other containing Xvent-2, Xom, Xbr-1 and Vox genes (Ladher et al., 1996; Onichtchouk et al., 1996; Papalopulu and Kintner, 1996; Schmidt et al., 1996) . In an analogous fashion to BMP-4 (Fainsod et al., 1994; Hemmati-Brivanlou and Thomsen, 1995; Schmidt et al., 1995) , these genes are expressed in the ventral and lateral mesoderm and their ectopic expression leads to the same ventralized phenotype as observed with BMP-4. Moreover, the Xvent genes are activated by BMP signalling and are able to rescue the dorsalized phenotype obtained with the dominant negative type I BMP receptor. Thus, all the evidence suggests that Xvent genes are downstream targets of BMP signalling and that they can mimic all the effects which are observed with BMP-4. In line with this, genes that are activated by BMP-4, like Xhox 3, Xwnt-8 and Xpo, can also be activated by Xvents, and dorsal genes which are suppressed by BMP-4, like goosecoid and Xnot, are also suppressed by Xvents (Gawantka et al., 1995; Onichtchouk et al., 1996 , Onichtchouk et al., 1998 . Moreover, we have recently shown that Xvent-1 mediates the BMP induced inhibition of the dorsal lip specific early response gene XFD-1′ by binding to the BIE motif as a direct transcriptional repressor (Friedle et al., 1998) .
Presently we report the identification of two novel Xvent genes, Xvent-1B and Xvent-2B, and characterize their 5′ flanking sequences. Interestingly, these genes are clustered with reverse orientation and their promoters, although being evolutionary conserved, contain distinct elements which may contribute to the differential expression of both genes. We further provide insight into the regulating mechanisms which govern the expression of Xvent genes in gastrulating embryos. Promoter deletion experiments have delineated the regions responsible for the activation by BMP-2/4. Cycloheximide experiments revealed that Xvent-2B, but not Xvent-1B, is directly activated by BMP signalling. However, Xvent-2B by itself is not sufficient to render transcriptional activation of the Xvent-1B gene.
Results

Xvent-1B and Xvent-2B: two novel members of the Xvent family
To study the genomic organization of Xvent genes and their transcriptional regulation, a Xenopus genomic DNA library was screened using Xvent-1 and Xvent-2 cDNAs (Gawantka et al., 1995; Onichtchouk et al., 1996) as labelled probes. Two novel genes, Xvent-1B and Xvent-2B, were isolated which are highly homologous but not identical to any other member of the Xvent gene family described so far. To investigate, whether these genes are faithfully transcribed in vivo, PCR was performed with a gastrula stage cDNA library using oligonucleotides derived from the conserved 5′ and the divergent 3′ untranslated regions (as compared to other Xvent cDNAs). This approach led to the isolation of Xvent-1B and Xvent-2B cDNAs which, by sequence analysis, fully correspond to their respective genomic sequences and, moreover, defined the exon/intron boundaries. Fig. 1 shows the amino acid sequences of Xvent-lB and Xvent-2B in comparison to those of the other known members of the Xvent family. The fact that eight Xvent genes have already been identified suggests the existence of a multigene family. This can be clearly subdivided into two Fig. 1 . Sequence comparisons of Xvent homeodomain proteins. The Xvent homeodomain family can be divided into two subfamilies. The Xvent-1 subfamily contains Xvent-1B, Xvent-1 (Gawantka et al., 1995) and PV.1 (Tidman Ault et al., 1996) , whereas Xvent-2B, Xbr-lb/Vox 1 (Papalopulu and Kintner, 1996; Schmidt et al., 1996) , Xvent2/Xbr-1a (Onichtchouk et al., 1996; Papalopulu and Kintner, 1996) , Vox 15 (Schmidt et al., 1996) and Xom (Ladher et al., 1996) belong to the Xvent-2 subfamily. The homeodomains are boxed. Arrowheads indicate the positions of introns within Xvent-1B or Xvent-2B genes, respectively. Identical amino acids are represented by dots. Note that an additional ATG within the Xvent-2B sequence gives rise to a putative extension at the N-terminus. different subfamilies sharing a rather conserved homeodomain (about 80% identity) but lacking any apparent homologies within the N-or C-terminal flanking regions of the corresponding proteins. Individual members of each subfamily exhibit 92-100% identity within their homeodomains and 82-99% over their entire sequences. Since Xenopus laevis is known to be a pseudo-tetraploid species, it may be anticipated that certain members within each subfamily represent pseudo-allelic versions of the same gene; however, the present sequence information is not sufficient to allow for such a pairwise combination. In any case, the growing number of reported genes clearly justifies the conclusion, that the Xvent family is formed by two subfamilies each of which containing several members with highly related sequences.
Transcription patterns and ectopic expression
The spatial transcription patterns of Xvent-1B and Xvent-2B genes have been analyzed by whole mount in situ hybridizations. As shown in Fig. 2 , Xvent-1B expression at the early gastrula stage is restricted to the ventral mesoderm. Transcripts persist during neural stages at the ventral region of the slit blastoporus and are even visible at stage 24 within the region of the future proctodeum. In contrast, Xvent-2B is not restricted to the ventral mesoderm but is also found in all lateral parts of mesoderm with the exception of the most dorsal cells, which contribute to the Spemann organizer. At later stages, the dorsal midline is devoid of any transcripts. Between stages 25 and 30, transcripts accumulate within the anterior/dorsal region of the eye, the otic vesicle, in neural crest derived head mesenchyme, in posterior neural crest cells and in the posterior region of the trunk. Stage 35 embryos show intense staining in the tip of the tail. The observed patterns are completely identical with the patterns which have already been reported for the other members of the Xvent-1 or Xvent-2 subfamilies, respectively. Noteworthy, the BMP-4 pattern exactly corresponds to that of all members of the Xvent-2 subfamily.
The effects of ectopic expression of Xvent-1B or Xvent-2B were studied by microinjection of RNA into the dorsal or ventral blastomeres of four-cell stage embryos. While ventral expression afforded normal embryos (data not shown), dorsal injections yielded in both cases, in a dose dependent manner, completely ventralized phenotypes which ultimately resulted in a 'Bauchstück' formation. Thus, phenotypic effects observed after ectopic expression of Xvent-1B, as well as of Xvent-2B, are indistinguishable from those which have previously been reported for the other members of the two subfamilies. 2B genes. Sequencing of three genomic clones revealed complete identities within the overlapping regions. The two genes are neighbouring, thereby forming a cluster and have probably arisen by gene duplication. However, duplication must have been followed by inversion, because the 5′ to 3′ orientation is on opposite strands. While we do not know in detail the extent of DNA inversion, it was not limited to the gene but also included the flanking sequences (see below). The distance between the two genes comprises about 10 kb. Transcription start sites have been determined by 5′ RACE and are, for both genes, located 30 nucleotides downstream of a canonical TATAAA box. Each gene is composed of three exons and the homeodomains are interrupted by the second introns at homologous positions (Fig. 1) . Another strong argument for the common evolutionary origin of both genes becomes obvious by comparison of the 5′ flanking sequences (Fig.  3B ). Within the 180 to 190 nucleotides being located most proximal to the start site, we observe an identity of more than 60%, a value which significantly decreases for further upstream sequences. Thus, the most proximal sequence must have undergone a strong selection pressure, while more distal sequences became mutated and are probably responsible for distinct regulatory mechanisms resulting in different spatial expression patterns of these genes.
Clustered organization, gene structure and promoter sequences
Promoter activities of 5′ flanking regions
To delineate the regions in the 5′ flanking sequences responsible for the regulation of the Xvent-1B and Xvent-2B genes, a series of deletion mutants fused to the luciferase reporter gene have been constructed. These constructs were injected either into dorsal or ventral blastomeres of four-cell stage embryos and luciferase activities were determined at stage 11. Fig. 4 demonstrates that for the Xvent-1B and Xvent-2B genes 249 or 275 bp, respectively, of the 5′ flanking region are sufficient to generate strong promoter activities and to confer to a ventral preference of reporter gene expression. These features are gradually lost with all further deletions. Thus, in case of Xvent-1B the -249/-164 region and, in case of Xvent-2B, the -275/-174 region play an important role for the spatial activation of Xvent transcription.
Since expression of both genes is induced by BMP-2/4 signalling (see below), we have investigated the influence of co-injection of BMP-4 and dominant negative BMP type I receptor (tBR) RNA on the promoter constructs. As shown in Fig. 4 , dorsal co-injections of BMP-4 RNA with Xvent-1B or Xvent-2B promoter/reporter constructs lead to a significant increase of reporter expression, whereas ventral co-injections of tBR downregulate both types of promoters. We used dorsal injections for the activator and ventral injections for the inhibitor, because under these circumstances the observed effect was more pronounced; however, similar results were also obtained when co-injections were performed with the other two blastomeres.
To investigate the ability of Xvent-1B and Xvent-2B to regulate each other, we have focused on their action on promoter activation. Interestingly, Xvent-1B failed to activate Xvent-2B, whereas Xvent-2B was able to upregulate both, the Xvent-1B and the Xvent-2B promoter. In addition downregulation of Xvent-1B obtained by tBR can be overcome by Xvent-2B; however, we have never observed a comparatively strong re-activation of the Xvent-2B promoter. Thus, it seems that BMP-4 signalling activates the Xvent-2B gene and that overexpression of Xvent-2B leads to activation of the Xvent-1B promoter. The observation of Xvent-2B auto-activation can be readily explained by the fact that the BMP-4 gene is strongly activated by Xvent-2B (Onichtchouk et al., 1996 ; our own unpublished data). In turn, elevated levels of BMP-4 transcription will activate Xvent-2B. In line with this assumption we find that co-injection with tBR abolishes the auto activatory effect of Xvent-2B.
Xvent-1B as a downstream target of Xvent-2B
The results of the promoter studies as well as the restricted expression pattern of Xvent-1B as compared to that of Xvent-2B suggest that Xvent-1B is a downstream target of Xvent-2B. To confirm this hierarchy, whole mount in situ hybridizations after dorsal injection of either Xvent-1B or Xvent-2B RNAs were performed. Fig. 5 shows that Xvent-2B leads to an activation of Xvent-1B within the dorso/lateral and the most dorsal mesoderm. In contrast Xvent-1B RNA injection failed to activate Xvent-2B in the dorsal lip. Therefore, the results suggest that Xvent-1B can be activated by Xvent-2B but not vice versa. Although these findings support previous results obtained by RT-PCR, it should be mentioned that activation of Xvent-2 has been observed within the lateral mesoderm after injection of Xvent-1 in LiCl-dorsalized embryos (Onichtchouk et al., 1996) . However, this situation might imply different mechanisms such as spatial activation and interactions of factors normally not present throughout the entire mesoderm.
Rescue of dominant-negative Xvent-2 by Xvent-1B
Our results provide strong evidence for Xvent-2B being upstream of Xvent-1B and that Xvent-2B functions as an activator of Xvent-1B. To gain additional support for this epistatic relationship we made use of a recently described dominant-negative Xvent-2 mutant (Xvent-2 P(40)) containing a L/P amino acid exchange preceding the third helix of the homeodomain (kindly provided by C. Niehrs, Heidelberg). As shown by ventral co-injection of Xvent-1B promoter/luciferase construct with Xvent-2 P(40) RNA, this mutant has the ability to suppress Xvent-1B promoter activity, but this suppression can be overcome by injection of Xvent-2B RNA (Fig. 6A ). In line with this, upregulation of the Xvent-1B promoter by co-injection with Xvent-2B RNA into dorsal blastomeres can be efficiently reduced by coinjection with Xvent-2 P(40).
To investigate the ability of Xvent-1B to rescue the phenotype created by the Xvent-2 P(40) mutant, we injected both RNAs separately into the dorsal or ventral blastomeres.
As previously shown (Onichtchouk et al., 1998) , ventral injection of Xvent-2 P(40) results in the formation of a secondary axis, whereas dorsal injection of Xvent-1B leads to a ventralization (Fig. 6B,D) . Here we show, that ventral co-injection of Xvent-2 P(40) with Xvent-1B RNA leads to a complete rescue and abolishes the effect caused by the dominant-negative Xvent-2 mutant (Fig. 6C) . However, the ventralization caused by Xvent-1B after dorsal injection can not be rescued by Xvent-2 P(40) (Fig. 6E ). These findings demonstrate that Xvent-1B is able to rescue the phenotype created by the dominant-negative Xvent-2 mutant to normal embryos but that this mutant cannot compensate for the phenotype obtained after overexpression of Xvent-1B. They render additional support for the notion that the Xvent-1B gene is a downstream target of Xvent-2 genes.
Cycloheximide prevents activation of the Xvent-1B but not of the Xvent-2B gene
Results from promoter analysis and ectopic expression suggest that Xvent-1B is a downstream target of Xvent-2B. If de novo synthesis of intermediate factors is not required, we would expect that this activation might only be dependent on Xvent-2B synthesis. Furthermore, cycloheximide (CHX) treatment should reveal, whether the activation of the Xvent-2B gene by BMP-signalling is direct or indirect. We have therefore injected BMP-4 or Xvent-2B RNA into embryos at the four-cell stage, added cycloheximide before midblastula transition at stage 7.5 and have monitored by RT-PCR the transcripts of Xvent-1B and Xvent-2B genes when control embryos had reached midgastrula (stage 10.5). Fig. 7 demonstrates that treatment of control embryos with CHX leads to a significant decrease of Xvent-1B and Xvent-2B transcripts (a very weak band remaining in the latter case might be due to endogenous BMP-2 synthesis prior to MBT), whereas synthesis of BMP-4 prior to CHX treatment leads to an activation of Xvent-2B but not of Xvent-1B gene (note that both genes are strongly induced by BMP-4 without CHX). Thus, while Xvent-2B is a direct target of BMP signalling, Xvent-1B is not. This behavior was not unexpected, since both the Xvent-1B promoter fragment as well as the wild type gene were activated by Xvent-2B suggesting that Xvent-2B serves as a mediator in BMP induced activation. This activation is also detected by RT-PCR in Xvent-2B injected embryos, but, surprisingly, we found that it is completely abolished by CHX treatment. Inhibition of de novo protein synthesis after prior synthesis of Xvent-2B results in a complete loss of Xvent-1B activation.
Discussion
Xvent family members as mediators of BMP-2/4 induced effects
Here we describe the genomic structure and promoter sequences of two novel Xvent genes Xvent-1B and Xvent-2B, which are closely related but not identical with the previously reported Xvent-1 and Xvent-2 cDNAs (Gawantka et al., 1995; Onichtchouk et al., 1996) . Apparently, the Xvent family is a multigene family which can be divided into two subfamilies, the prototypes of which may be regarded as Xvent-1 or Xvent-2, respectively. An additional member of the Xvent-1 subfamily is PV.1 (Tidman Ault et al., 1996) , whereas Xom, Xbr and Vox genes belong to the Xvent-2 subfamily (Ladher et al., 1996; Papalopulu and Kintner, 1996; Schmidt et al., 1996) . While the temporal as well as the spatial expression patterns of all genes within a given subfamily seem to be similar or even identical, there are obvious differences between the two subfamilies. While Xvent-1B and Xvent-2B genes are expressed in ventral and Fig. 7 . Interactions between BMP-4, Xvent-2B and Xvent-1B in whole embryos in the absence or presence of cycloheximide (CHX). Four-cell stage embryos have been injected with BMP-4 RNA (300 pg) or Xvent-2B RNA (400 pg) into both dorsal blastomeres. Cycloheximide treatment started at stage 7.5 and embryos were cultured until stage 10.5. RT-PCR was performed with total RNA and has been adjusted using histone H4 as an internal control.
ventro/lateral mesoderm, the Xvent-2B gene shows additional expression in the lateral and dorso/lateral mesoderm except for the dorsal lip. During all stages of embryonic development, Xvent-2B expression is identical to that of BMP-4. This might be interpreted in that the mutual regulations between these two genes are much closer than those between BMP-4 and Xvent-1. Although the latter can also be induced by BMP-4, we show here that activation is mediated by Xvent-2 and that additional factors are required which are synthesized after midblastula transition.
Xvent family members act as downstream targets of BMP-4. They mediate BMP-4 induced effects including patterning of the ventral mesoderm (Dosch et al., 1997) , inhibition of neural induction and converting ectodermal cells into an epidermal cell fate (Wilson and Hemmati-Brivanlou, 1995) . Dorsal injections of both Xvent-1B or Xvent-2B, lead in a dose-dependent manner, to a complete ventralization like that observed with BMP-2/4 (Dale et al., 1992; Jones et al., 1992; Clement et al., 1995) . In this context it is worth noting that Xvents do not only mimic all the effects observed with BMP-4 and that they can rescue the phenotype obtained with the truncated BMP receptor, but that they are also transcribed within the animal hemisphere of early gastrula stage embryos (data not shown), thereby mediating the specification of the prospective neural ectoderm (Tidman Ault et al., 1997) . Two major questions arise from all these observations. Why are the BMP effects mediated not by only one but by a large number of similar proteins showing identical expression patterns and functional properties? Furthermore, provided Xvents mediate BMP effects, what is known about their homologues in other species? It may be argued that the functional importance of Xvents in mediating BMP effects has been ensured by gene duplications leading to functional redundancy; however, this is hard to believe in lack of any precedents. Also, while there seems to be a similar function for the HOX11 related Tlx-2 gene as downstream target of BMP signalling in the mouse embryo (Tang et al., 1998) , in view of divergent sequences and genomic structures (Cheng and Mak, 1993) it is rather unlikely that Tlx genes represent the mouse orthologues of Xvent genes (note however, that they form a gene family and that they exhibit an isoleucine or valine to threonine exchange within the third helix of their homeodomain). Thus, additional information on the individual Xvent proteins as well as isolation of more closely related genes from other species are necessary to answer these questions.
Genomic sequences and promoter functions
Sequencing of overlapping genomic clones revealed that the Xvent-1B and Xvent-2B genes are clustered. Interestingly, duplication must have been followed by inversion, because transcription proceeds from opposite strands. Such inversions have also been observed within the Antennapedia complex (ANT-C) of different Drosophila species (Maier et al., 1990; Randazzo et al., 1993) . While in ANT-C of D. melanogaster the Deformed gene (Dfd) and the pair rule gene fushi tarazu (ftz) show an inverse orientation, ftz in D. hydei and Dfd in D. pseudoobscura are 5′ to 3′ directed like the other genes within this complex. Obviously, these inversions can occur without compromising gene function. The fact, that Xvent-1B and Xvent-2B are clustered raises the question whether the other Xvent genes are also organized in such clusters or whether the remaining genes of the Xvent-1 family are located more upstream and the other Xvent-2 family members more downstream, in a way that we have accidentally hit the breakpoint between Xvent-1 and Xvent-2 gene clusters. Genomic walking experiments are currently performed to solve this problem. Interestingly, it had been speculated that Xvent genes may specify different dorso/ventral expression boundaries like HOX genes define anterior expression boundaries proceeding in an anterior/posterior order colinear with their chromosomal location (McGinnis and Krumlauf, 1992; Onichtchouk et al., 1996) . Our results suggest that this might be the case, but the observed inversion presently prevents any statements on a correlation of dorsal to ventral expression with gene arrangements.
A comparison of Xvent-1B and Xvent-2B genomic structures and their 5′ flanking sequences reveals striking similarities. Both genes are composed of three exons, with the second intron interrupting the homeobox at identical positions. Additionally, more than 60% identity within the most proximal located 180-190 bp upstream region argues for a common evolutionary origin of these genes by a duplication event.
Serial deletion mutants of the 5′ flanking sequences from both genes delineated the regions which contribute not only to the activation of these genes, but also show a ventral to dorsal preference These regions are located at -249/-164 in the case of Xvent-1B and at -275/-220 for the Xvent-2B gene. In line with the results obtained from dorsal injections of BMP-4 RNA and subsequent RT-PCR for Xvent-1B and Xvent-2B, the corresponding promoter deletion/reporter constructs are activated by co-injection with BMP-4 RNA and they are down-regulated by tBR. Although the promoter nucleotide sequence was not reported, a most proximal upstream fragment of the Xvent-2 gene had already been shown to respond to BMP signalling and to compete for the intracellular pool of Smad4 (Candia et al., 1997) .
Epistatic relationship between Xvent-1B and Xvent-2B
The question whether both genes directly respond to BMP or whether activation of one gene is subordinate to the other was addressed by several strategies. First, while both promoters are activated by co-injection with Xvent-2B RNA, the Xvent-2B promoter does not respond to Xvent-1B RNA injection. Interestingly, inhibition of BMP signalling by co-injection of tBR together with Xvent-2B RNA abolished the activatory effect on the Xvent-2B but not on the Xvent-1B promoter which can be upregulated by Xvent-2B even in the presence of tBR. Secondly we could show by whole mount in situ hybridization, that Xvent-2B activates Xvent-1B, but not vice versa. Third, a dominant-negative Xvent-2 mutant (Xvent-2 P(40)) is able to suppress luciferase activity driven by the Xvent-1B promoter. In addition, secondary axis induced by Xvent-2 P(40) could be rescued by wild-type Xvent-1B, whereas Xvent-1B induced ventralization could not be rescued by Xvent-2 P(40). Fourth, injection of BMP-4 RNA in four cell stage embryos with subsequent cycloheximide treatment at stage 7.5 resulted in the activation of the Xvent-2B but not of the Xvent-1B gene. Fifth, we have found, that Xvent-2B, but not Xvent-1B, leads to an activation of the BMP-4 gene (Onichtchouk et al., 1996; our own unpublished data) . Thus, all these data suggest that BMP-4 activates Xvent-2B by direct signalling and that Xvent-2B activates in turn the BMP-4 gene as well as the Xvent-1B gene. We have recently shown, that the Xenopus BMP-4 gene contains several enhancers which respond to BMP-2/4 (Metz et al., 1998) , thereby confirming the autoregulatory loop reported previously (Jones et al., 1992) . Meanwhile, we could demonstrate that this auto-activation is mediated by Xvent-2, but not by Xvent-1 (manuscript in preparation). In conclusion, Xvent-2B is a direct response gene for BMP-4 signalling which is substantiated by identical expression patterns observed with these genes. Xvent-1B is downstream of Xvent-2B and its activation by components of the BMP signalling pathway is indirect.
Regulation of the Xvent-1B gene
Injection of Xvent-2B RNA upregulates the wild type Xvent-1B gene as well as the Xvent-1B promoter. However, we have found that overexpression of Xvent-2B prior to cycloheximide treatment of embryos at stage 7.5 is not sufficient to render transcription of Xvent-1B after midblastula transition. This observation can only be interpreted by the need for additional factor(s) to be synthesized after MBT. Such a factor could either bind to the Xvent-1B promoter directly and independently from Xvent-2B, or it could also interact with Xvent-2B and may be required as transactivator mediating the activating properties of Xvent-2B to the basal transcription initiation complex. In this context it has to be noted that injection of a fusion construct in which the N-terminal domain of Xvent-2 had been replaced by the VP16 activatory domain leads to a downregulation of many ventral genes including Xvent-1 and an upregulation of dorsal genes, like goosecoid and Otx2 (Onichtchouk et al., 1998) . While we do not know at the moment, whether under these circumstances the enhanced dorsal gene activity is responsible for suppression of Xvent-1, it is also possible that replacement of the N-terminal domain abolishes the interaction of Xvent-2 with other factors binding to the promoter and being essential for Xvent-1 activation. This would be in line with the results obtained by using the Xvent-2 P(40) mutant. If Xvent-2 needs an additional factor to activate Xvent-1, Xvent-2 P(40) might compete for this factor, which then is not available for the wild-type protein. These alternatives are of general importance, because they enlighten a possible dual role for Xvent proteins. They may either be regarded as transcriptional repressors for dorsal genes thereby allowing ventral gene expression, or they serve as transcription activators for ventral genes subsequently suppressing dorsal gene activities. Are different Xvent proteins specialized for these alternative functions? We are presently elucidating this question by performing domain swapping experiments between Xvent-1B and Xvent-2B.
Our results also imply the necessity of additional factor(s) which cooperate with Xvent-2B in the activation of Xvent-1B. The list of candidates comprises all those genes which have previously been reported to activate Xvent-1 expression, like Wnt-8 (Hoppler and Moon, 1998) , GATA-2 (Sykes et al., 1998) and Xcad-2 genes (Pillemer et al., 1998) , or the ventralizing and anti-neuralizing BMP immediate response gene msxl (Suzuki et al., 1997) , but other, yet unknown factors can not be excluded. We will therefore investigate the activatory potential of known factors for their cooperative effects with Xvent-2B in the presence of cycloheximide, and we will simultaneously concentrate on the identification of new factors interacting with Xvent proteins.
Materials and methods
Isolation of genomic clones
A Xenopus laevis genomic DNA library was screened using Xvent-1 or the Xvent-2 cDNA (kindly provided by C. Niehrs, Heidelberg) as labelled probes. This led to the isolation of three recombinant clones containing the Xvent-1B or Xvent-2B gene, respectively. Sequence analysis of genomic clones revealed complete identity within their overlapping regions. Subclonings were done according to standard procedures and sequencing was performed with fluorescence labelled dye terminators using an ABI 377 sequencer. The region starting from the EcoRI site upstream of Xvent-1B and ending at the phage arm upstream of Xvent-2B comprises 17.8 kb and has been sequenced. Xvent-1B and Xvent-2B genomic sequences have been deposited at EMBL data bank (accession nos. AJ131094, AJ131095).
5′ RACE
Total RNA was isolated from embryos at the gastrula stage. One microgram of RNA was used as template in the 5′ RACE system (Version 2.0/GIBCO BRL). Xvent-1B cDNA was prepared using the antisense oligonucleotide GSP1 (5′-GTACATCTTGTCCATCCTTC), tailed by poly(dC) and amplified by PCR using the internal primer GSP2 (5′-GCATCTCCTTGGCATATTTGG) and the abridged anchor primer (GIBCO BRL). For Xvent-2B cDNA, the antisense oligonucleotide GSP1 (5′-GTC-CCTGTGTAGCAATCCATTG) and the internal primer GSP2 (5′ ACTGTCTGAGGAATATGGAG) were used.
Promoter deletion mutants
Various deletions of the 5′-flanking region of Xvent-1B and Xvent-2B genomic clones were generated by PCR, employing appropriate primers containing restriction sites for BamHI at the 5′-end or HindIII at the 3′-end. These promoter fragments were cloned into the BglII and HindIII sites of the pGL3 vector (Promega). Xvent-1B: 5′-deletion mutants primers (all sequences are from 5′ to 3′): -382: CCAGTCTCCTGGTGTGACTT; -249: ATGGGATTCT-GTGCCG; -193: AAGGTGAAATCACTAACCT; -164: ACTGGAGCCAGGACCAGG; -84: ATTTCTGGTTC-TCC. Xvent-1B reverse 3′ primer: CTGAAGGGAA-GGCTGCT. Xvent-2B 5′-deletion mutants primers (all sequences are from 5′ to 3′): -275: GAGAGGCTTCCCAA-TAGCTA; -220: GTAAATTGGGCTACTGG; -174: GG-AGCCAGCTCTTAGTGAGA; Xvent-2B reverse 3′ primer: CTGTATTAGTCCTTGTGTTC. The -371 mutant extends from an XbaI site to a HindIII site within the first exon.
Embryo injections and luciferase assay
5′ Promoter deletion mutants were injected at 20 pg/blastomere into four-cell stage embryos either into the dorsal or the ventral blastomeres. When indicated, RNA was coinjected into individual blastomeres. Injected embryos were collected at stage 11 (staging according to Nieuwkoop and Faber, 1975) and deep frozen in liquid nitrogen. Luciferase assay was carried out as described (Friedle et al., 1998) .
Embryos and whole mount in situ hybridization
In vitro fertilization, embryo culturing and whole mount in situ hybridizations were carried out as described (Kaufmann et al., 1996) .
Constructs
Xvent-lB and Xvent-2B cDNAs have been amplified by PCR using a Xenopus gastrula cDNA library as template. Xvent-1B was cloned into KpnI and BglII sites of pSP64T3 vector for RNA injection, or into KpnI/BamHI sites of pSPT19 for whole mount in situ hybridization. Xvent-2B was cloned into BamHI/EcoRI sites of pCS2 (Rupp et al., 1994) vector for injection or into BamHI/EcoRI sites of pBS KS + vector for generating antisense RNA. Xvent-1B upstream primer: 5′-GCCGGTACCAGAG-CAGGCTTCCCTTCAGC Xvent-1B downstream primer: 5′-GCCAGATCTG-TTCCTTAGTTCCAGAGCTG Xvent-2B upstream primer: 5′-CGGGATCCATGAC-TAAAGCTTTCTCCTC Xvent-2B downstream primer: 5′-CGAATTCCTTT-GAATTGGCCTCAAAC.
RT-PCR
Embryos have been injected at the four-cell stage with Xvent-2B (400 pg) or BMP-4 RNA (300 pg) respectively, into both dorsal blastomeres. At stage 7.5 embryos were treated with 7.5 mg/ml cycloheximide until control siblings reached stage 10.5. Total RNA was isolated using RNeas, mini-columns (Qiagen; RNeasy mini protocol for isolation of total RNA from animal tissues). After cDNA synthesis with Superscript II (Life Technologies), PCR was performed for histone H4 (upstream primer: 5′-CGGGAT-AACATTCAGGGTATCACT-3′; downstream primer: 5′-ATCCATGGCGGTAACTGTCTTCCT-3′), Xvent-1B (upstream primer: 5′-TTCCCTTCAGCATGGTTCAA-3′; downstream primer: 5′-GCATCTCCTTGGCATATTTGG 3′) and Xvent-2B (upstream primer: 5′-CCTCATGGACA-CAAGGACTA-3′; downstream primer: 5′-GATACTT-CACTGTTCCAGGA-3′). The following conditions were used for all probes: 56°C annealing temperature, 27 cycles.
